Forget Novo Nordisk: Buy This Magnificent Pharma Stock Instead

Vertex Pharmaceuticals has a lot going for it. Novo Nordisk (NVO 1.42%) is enjoying one of the best seasons in its history. Two of the company's drugs, Ozempic and Wegovy, have become household names. Novo's sales and profits are soaring. So is its share price, with the stock up around 150% over the last three years. Some investors who didn't buy Novo Nordisk earlier could be considering jumping on the bandwagon now. I have an alternate idea. Forget Novo Nordisk and buy another magnificent pharma stock inst ...